Aß Toxicity in Alzheimer’s Disease

作者: William L. Klein

DOI: 10.1007/978-1-59259-006-3_1

关键词:

摘要: The first diagnosed Alzheimer’s disease patient was Auguste D (Fig. 1), a middle-aged woman cared for by Alsatian clinician-pathologist Alois Alzheimer from 1901 to 1906. died in her middle fifties, and Alzheimer, aided new histochemical methods, found brain tissue corrupted an abundance of extracellular intracellular lesions, the now-familiar plaques tangles (1). research provided direct evidence that dementia is consequence neurodegenerative mechanisms, not simple fact aging. A less diagnostic but equally apt description also came care D. As he tracked his patient’s progressively severe dementia, once asked write name. She task impossible replied, “I have lost myself” (2). We now know (AD) most common cause older individuals. number patients has grown case 1906 estimated 25 million worldwide (3). Complications resulting AD constitute fourth leading death United States, annual cost economy exceeds $140 billion (4,5). elderly population continues grow rapidly, represents imminent social as well medical problem.

参考文章(305)
P.L. McGeer, H. Akiyama, S. Itagaki, E.G. McGeer, Immune system response in Alzheimer's disease. Canadian Journal of Neurological Sciences. ,vol. 16, pp. 516- 527 ,(1989) , 10.1017/S0317167100029863
Robbert H. COOL, Evelyne MERTEN, Christiane THEISS, Helmut ACKER, Rac1, and not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells. Biochemical Journal. ,vol. 332, pp. 5- 8 ,(1998) , 10.1042/BJ3320005
K Eguchi, Y Kawabe, K Migita, S Nagataki, Tyrosine phosphorylation participates in peripheral T-cell activation and programmed cell death in vivo. Immunology. ,vol. 85, pp. 550- 555 ,(1995)
De-Hua Chui, Hiroshi Tanahashi, Kazuharu Ozawa, Sachiya Ikeda, Frédéric Checler, Otoya Ueda, Hiroshi Suzuki, Wataru Araki, Haruhisa Inoue, Keiro Shirotani, Keikichi Takahashi, Ferenc Gallyas, Takeshi Tabira, Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation Nature Medicine. ,vol. 5, pp. 560- 564 ,(1999) , 10.1038/8438
Pearce Br, Palmer Am, Esiri Mm, Wilcock Gk, Bowen Dm, Davison An, Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Neurochemical Pathology. ,vol. 2, pp. 221- 232 ,(1984)
R. D. Terry, The cytoskeleton in Alzheimer disease Journal of Neural Transmission. Supplementa. ,vol. 53, pp. 141- 145 ,(1998) , 10.1007/978-3-7091-6467-9_12
C. Behl, Y. Sagara, Mechanism of amyloid β protein induced neuronal cell death: current concepts and future perspectives Advances in Research on Neurodegeneration. ,vol. 49, pp. 125- 134 ,(1997) , 10.1007/978-3-7091-6844-8_14
Steven G. Younkin, The role of Aβ42 in Alzheimer's disease Journal of Physiology-Paris. ,vol. 92, pp. 289- 292 ,(1998) , 10.1016/S0928-4257(98)80035-1
Ch. Czech, C. Masters, K. Beyreuther, Alzheimer’s disease and transgenic mice Journal of Neural Transmission-supplement. ,vol. 44, pp. 219- 230 ,(1994) , 10.1007/978-3-7091-9350-1_17